The DOI matches its Crossref record.
Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1
Abstract
Experimental allergic encephalomyelitis (EAE) is an autoimmune disease characterized by inflammation and demyelination in the central nervous system. The effect of the immunosuppressive molecule transforming growth factor-beta, (TGF-beta 1) on chronic relapsing EAE produced by the transfer of myelin basic protein-specific T cell lines was studied. TGF-beta 1 markedly inhibited the activation and proliferation of myelin-basic protein-specific lymph node cells in vitro. This reduced the capacity of these cells to transfer EAE. In addition, administration of TGF-beta 1 in vivo consistently resulted in an improved clinical course, even when given during ongoing disease. Immunopathologic study demonstrated a marked reduction in central nervous system damage and expression of cell-surface lymphocyte function-associated Ag-1 and class II MHC molecules in TGF-beta 1-treated mice. These findings have identified TGF-beta 1 as a possible therapeutic agent for the human demyelinating disease multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A.-K. L., & Flavell, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090737 · Cited by 2,206
McGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T., & Cua, D. J. (2007) · Nature Immunology · doi:10.1038/ni1539 · Cited by 1,520
Gold, R. (2006) · Brain · doi:10.1093/brain/awl075 · Cited by 1,017
“Its efficacy seemed to be connected with secretion of TGF-b (Khoury et al., 1992; Miller et al., 1992), which was effective in blocking EAE in vivo (Racke et al., 1991).”
BackgroundTransforming growth factor-beta: recent progress and new challenges.
Sporn, M. B., & Roberts, A. B. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.5.1017 · Cited by 769
T he P athogenesis of O ral L ichen P lanus
Sugerman, P. B., Savage, N. W., Walsh, L. J., Zhao, Z. Z., Zhou, X. J., Khan, A., Seymour, G. J., & Bigby, M. (2002) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130201300405 · Cited by 768
The adhesion molecule and cytokine profile of multiple sclerosis lesions
Cannella, B., & Raine, C. S. (1995) · Annals of Neurology · doi:10.1002/ana.410370404 · Cited by 763
Self-citationPhysiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)
Roberts, A. B., & Sporn, M. B. (1993) · Growth Factors · doi:10.3109/08977199309029129 · Cited by 755
Miller, A., Lider, O., Roberts, A. B., Sporn, M. B., & Weiner, H. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.421 · Cited by 732
Khoury, S. J., Hancock, W. W., & Weiner, H. L. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.5.1355 · Cited by 708
Sloan-Lancaster, J., & Allen, P. M. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.1 · Cited by 676
Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection
Sanjabi, S., Oh, S. A., & Li, M. O. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022236 · Cited by 621
Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease.
Racke, M. K., Bonomo, A., Scott, D. E., Cannella, B., Levine, A., Raine, C. S., Shevach, E. M., & Röcken, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1961 · Cited by 594
Self-citationLafaille, J. J., Nagashima, K., Katsuki, M., & Tonegawa, S. (1994) · Cell · doi:10.1016/0092-8674(94)90419-7 · Cited by 532
T Cell Deletion in High Antigen Dose Therapy of Autoimmune Encephalomyelitis
Critchfield, J. M., Racke, M. K., Zúñiga-Pflücker, J. C., Cannella, B., Raine, C. S., Goverman, J., & Lenardo, M. J. (1994) · Science · doi:10.1126/science.7509084 · Cited by 524
Self-citationTransforming growth factor beta: the good, the bad, and the ugly.
Wahl, S. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1587 · Cited by 486
Polygenic control of susceptibility to murine systemic lupus erythematosus
Morel, L., Rudofsky, U. H., Longmate, J. A., Schiffenbauer, J., & Wakeland, E. K. (1994) · Immunity · doi:10.1016/1074-7613(94)90100-7 · Cited by 471
Macrophages and the Recovery from Acute and Chronic Inflammation
Hamidzadeh, K., Christensen, S. M., Dalby, E., Chandrasekaran, P., & Mosser, D. M. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034348 · Cited by 437
Transforming growth factor beta (TGF-?) in inflammation: A cause and a cure
Wahl, S. M. (1992) · Journal of Clinical Immunology · doi:10.1007/bf00918135 · Cited by 407
Cytokine Actions in the Central Nervous System
Benveniste, E. N. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)00015-x · Cited by 383
Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis
Martin, R., McFarland, H. F., & Boggs, J. M. (1995) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369509084683 · Cited by 376
Less Mortality but More Relapses in Experimental Allergic Encephalomyelitis in CD8 -/- Mice
Koh, D.-R., Fung-Leung, W.-P., Ho, A., Gray, D., Acha-Orbea, H., & Mak, T.-W. (1992) · Science · doi:10.1126/science.256.5060.1210 · Cited by 352
Chen, W., Jin, W., & Wahl, S. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1849 · Cited by 352
Watson, M. L., Rao, J. K., Gilkeson, G. S., Ruiz, P., Eicher, E. M., Pisetsky, D. S., Matsuzawa, A., Rochelle, J. M., & Seldin, M. F. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1645 · Cited by 338
Theiler's Virus Infection: a Model for Multiple Sclerosis
Oleszak, E. L., Chang, J. R., Friedman, H., Katsetos, C. D., & Platsoucas, C. D. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.174-207.2004 · Cited by 308
The Dale E. McFarlin memorial lecture: The immunology of the multiple sclerosis lesion
Raine, C. S. (1994) · Annals of Neurology · doi:10.1002/ana.410360716 · Cited by 285
Self-citationThe Inhibitory Effects of Transforming Growth Factor-Beta-1 (TGF-β1) in Autoimmune Diseases
Prud'homme, G. J., & Piccirillo, C. A. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.1999.0339 · Cited by 276
Inflammation in Traumatic Brain Injury: Role of Cytokines and Chemokines
Ghirnikar, R. S., Lee, Y. L., & Eng, L. F. (1998) · Neurochemical Research · doi:10.1023/a:1022453332560 · Cited by 261
Shaw, M. K., Lorens, J. B., Dhawan, A., DalCanto, R., Tse, H. Y., Tran, A. B., Bonpane, C., Eswaran, S. L., Brocke, S., Sarvetnick, N., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1711 · Cited by 260
Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?
Croxford, J. L., & Yamamura, T. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.04.023 · Cited by 255
Geiser, A. G., Letterio, J. J., Kulkarni, A. B., Karlsson, S., Roberts, A. B., & Sporn, M. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.9944 · Cited by 179
Wie�ner, C., Gehrmann, J., Lindholm, D., T�pper, R., Kreutzberg, G. W., & Hossmann, K. A. (1993) · Acta Neuropathologica · doi:10.1007/bf00228578 · Cited by 151
Paglinawan, R., Malipiero, U., Schlapbach, R., Frei, K., Reith, W., & Fontana, A. (2003) · Glia · doi:10.1002/glia.10286 · Cited by 122
Merson, T. D., Binder, M. D., & Kilpatrick, T. J. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8112-z · Cited by 84
MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis
Severin, M. E., Lee, P. W., Liu, Y., Selhorst, A. J., Gormley, M. G., Pei, W., Yang, Y., Guerau-de-Arellano, M., Racke, M. K., & Lovett-Racke, A. E. (2016) · Brain · doi:10.1093/brain/aww084 · Cited by 52
Self-citation
Metadata
- Authors
- Racke, M. K., Dhib-Jalbut, S., Cannella, B., Albert, P. S., Raine, C. S., & McFarlin, D. E.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1991-05-01
- Volume
- 146
- Issue
- 9
- Pages
- 3012-3017
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1906640112
- Cited by
- 378
- References
- 0
- FWCI
- 26.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.